BioSpace News Archive

NanoImaging Services, the leading provider of cryo-electron microscopy services to the pharmaceutical and biotechnology communities, announced that it has received a growth equity investment from Ampersand Capital Partners.

Veracyte, Inc. announced that three abstracts highlighting new data on the company’s Afirma test and capabilities will be presented at ENDO 2023, the annual meeting of The Endocrine Society, which is taking place June 15-18 in Chicago, Ill.

Lantern Pharma Inc. (NASDAQ: LTRN) today announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for LP-184, which is being developed for multiple advanced solid tumors and central nervous system (CNS) cancers.

Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare diseases, announces the publication of real-world evidence of AKYNZEO® (fosnetupitant with palonosetron) injection/for injection in the journal Advances in Therapy.

SomaLogic, Inc., a leader in proteomics technology, announced their collaboration with Citogen, the Longwood Group’s customer services and support unit, to establish the company’s first authorized site in Spain.

Medtronic plc, a global leader in medical technology, announced its participation in the upcoming American Diabetes Association’s 83rd Scientific Sessions in San Diego on Jun. 23-26, 2023.

IVIVA Medical won a Phase 2 KidneyX Prize from the Kidney Innovation Accelerator, a public-private partnership between the American Society of Nephrology and the US Department of Health and Human Services, for its work developing a fully implantable bioartificial kidney.

Biostar Pharma, Inc. is pleased to announce that the first patient has been enrolled today for a Phase 1 clinical study (BG02-2201; NCT05681000) of its proprietary oral formulation product of utidelone, UTD2 (utidelone capsule) in advanced solid tumor patients in the US.

American Aires Inc. (CSE: WIFI) (OTC: AAIRF) (“Aires” or the “Company”), a leader in scientifically-proven EMF modulation technology today announces that it has completed a series of debt conversions to decrease the Company’s debt.

Dietitians say a keto diet could help you lose up to 10% of your body weight. These high-fat, low-carb meal plans trick the body into burning its own fat.